1 Several trials reported
post hoc analyses.
2 otation of variants is typically inferred by
post hoc analyses.
3 d except those clearly marked as exploratory
post hoc analyses.
4 Results did not qualitatively differ in
post hoc analyses.
5 roblems of publication bias and questionable
post hoc analyses.
6 alyzed via analysis of variance and Fisher's
post hoc analyses.
7 000 SQ-T, Merck/ALK-Abello) were pooled for
post hoc analyses.
8 enriched blood was conducted for exploratory
post-hoc analyses.
9 up comparisons, and Mann-Whitney U tests for
post-hoc analyses.
10 DHD groups did not differ from each other in
post-hoc analyses.
11 In
post-hoc analyses,
5-year progression-free survival was
12 primary post-mortem diagnosis of non-AD, in
post hoc analyses,
active seizure participants had worse
13 Post hoc analyses additionally found increased connectiv
14 Post hoc analyses also revealed a main effect of MAOA ge
15 In
post hoc analyses among female never smokers, both PM2.5
16 ol to identify missing links, (v) systematic
post-hoc analyses and (vi) an R-Shiny tool to run CellNO
17 retation relies on computationally demanding
post hoc analyses,
and even then, one can often not expl
18 ical vs surrogate primary end points, use of
post hoc analyses,
and reporting of age and sex.
19 ginal studies due to the small sample sizes,
post hoc analyses,
and variable MA definitions.
20 pendent t test, chi2, Mann-Whitney test, and
post hoc analyses applied for associations.
21 Exploratory
post hoc analyses are reported for FAV patients, those r
22 Our
post-hoc analyses argue for an individualized TMS applic
23 Post hoc analyses assessed the frequency of reaching an
24 Post hoc analyses associated factors with symptoms and d
25 In
post hoc analyses based on adherence to AT, all-cause mo
26 In 10/115 (8.7%) studies
post-hoc analyses based on stratification for nutritiona
27 However, brain fMRI and
post hoc analyses by site suggest that walnuts might del
28 Univariate and multivariate
post hoc analyses compared effects of treatment and pati
29 In 9
post hoc analyses comparing patients initially prescribe
30 Findings of previous
post hoc analyses could not be validated in a trial usin
31 Independently, in
post hoc analyses,
CYP2C19*2 has been associated with wo
32 stimated by a semiparametric model, while in
post hoc analyses,
DAOH and percent DAOH were compared b
33 In
post hoc analyses,
daprodustat increased total (first an
34 nce interval, 0.47 to 0.76), and exploratory
post hoc analyses demonstrated differences in effectiven
35 Post hoc analyses demonstrated that the N1 deficit in ch
36 Post-hoc analyses demonstrated that it was shifting atte
37 Corrected
post-hoc analyses demonstrated that patients had signifi
38 However, in
post hoc analyses,
depressed patients showed hypermetabo
39 Results were consistent in a series of
post hoc analyses,
designed to assess potential biases.
40 Post hoc analyses determined the response rate and durat
41 Post hoc analyses did not find a significant increased r
42 Extensive
post hoc analyses did not identify any subgroup of HERS
43 lthy controls from MDD (p = 0.005); however,
post-hoc analyses did not reveal a significant associati
44 However, because
post hoc analyses do not conform to the randomization mo
45 integrate information from five studies and
post hoc analyses enhanced biological interpretations.
46 Post hoc analyses established that PdE concentration inc
47 In secondary and
post hoc analyses evaluating the potential impact of the
48 Post hoc analyses examined the heterogeneity of treatmen
49 The
post hoc analyses examined the relationship of neural ab
50 Post hoc analyses examined whether: (1) covarying for me
51 Post hoc analyses examining depressive symptom clusters
52 In
post hoc analyses,
FACT-BRM TOI scores favored the pembr
53 Results of
post hoc analyses for donanemab-treated participants sug
54 Some
post hoc analyses for exploring any specific pattern of
55 ection as users want more interpretation and
post-hoc analyses for biomarker detection.
56 Post hoc analyses found evidence of effect modification
57 Post hoc analyses found numerically fewer FMT recipients
58 Post hoc analyses found that medical doctors were consid
59 Furthermore, these
post hoc analyses found that vitamin D supplementation l
60 The
post-hoc analyses found that during the first visit, rel
61 Exploratory
post hoc analyses from a prior trial showed that vericig
62 We included all observational studies and
post hoc analyses from randomized controlled clinical tr
63 Importance:
Post hoc analyses from the Diabetic Retinopathy Clinical
64 We performed
post hoc analyses from the WOSCOPS (West of Scotland Cor
65 However,
post-hoc analyses from statin trials indicate that the v
66 Post hoc analyses further revealed that V-IH had signifi
67 Post-hoc analyses further confirmed strong correlations
68 In
post hoc analyses,
girls trafficked prior to age 15 year
69 In
post hoc analyses,
greatest benefit from ART-123 was see
70 Increasing numbers of
post hoc analyses have applied restricted mean survival
71 Post hoc analyses have suggested a range of other benefi
72 In
post hoc analyses,
hemagglutination inhibition (HI) tite
73 In
post hoc analyses,
higher baseline QUIP-RS and lower bas
74 In
post-hoc analyses,
HTI vaccines were associated with a p
75 multiple "peeks" at the data, and unplanned,
post hoc analyses (
i.e., "data dredging," "fishing exped
76 However,
post hoc analyses identified a responder profile; a pros
77 Post hoc analyses identified a similar pattern of result
78 Post hoc analyses identified group-level differences bet
79 evascularization (CABG) are equivalent, some
post hoc analyses in high-risk groups and adjustment for
80 , and the lack of a placebo group and use of
post hoc analyses in many trials.
81 In
post hoc analyses in nondiabetic individuals, a 1% incre
82 Post hoc analyses in patients who tolerated GDMT were al
83 Observational data and results from
post-hoc analyses in clinical trials suggest that direct
84 ials in clinically significant agitation but
post-hoc analyses in other populations found reduced agi
85 er); the effect of crossover was assessed in
post-hoc analyses,
in which responses achieved after cro
86 Post hoc analyses included change from baseline sodium l
87 Other
post hoc analyses included cognitive decline (fall in MM
88 Post hoc analyses included glycemic changes in the subgr
89 Post hoc analyses included mucus plug score change from
90 Post hoc analyses included restriction to term neonates,
91 Post hoc analyses included voxel-based morphometry and d
92 These
post hoc analyses indicate that patients with severe eos
93 Exploratory
post hoc analyses indicated a greater mPEF improvement b
94 Post hoc analyses indicated associations between platinu
95 Post hoc analyses indicated interactions between the int
96 n suicidal ideation was less clear, although
post hoc analyses indicated less severe suicidal ideatio
97 Post hoc analyses indicated no difference by age, sex, o
98 Post hoc analyses indicated that AOEs are dose dependent
99 Post hoc analyses indicated that greater modulation was
100 cingulate cortices (Brodmann's area 31), and
post hoc analyses indicated that subjects with Tourette'
101 Post-hoc analyses indicated divergent direction of effec
102 Post-hoc analyses indicated that effects were not signif
103 Post-hoc analyses indicated that racial differences may
104 However,
post-hoc analyses indicated that reduced recollective pr
105 Post-hoc analyses indicated that the young group had sig
106 Post-hoc analyses indicated this effect was driven by su
107 nia, trained to discriminate diagnosis, with
post-hoc analyses indicating prognostic properties.
108 In
post hoc analyses,
major adverse cardiovascular events (
109 to proliferative diabetic retinopathy (PDR),
post hoc analyses may influence treatment choices.
110 design and data reporting, as well as use of
post hoc analyses,
may have inflated the apparent benefi
111 In
post hoc analyses,
more HIV infections occurred in vacci
112 In
post hoc analyses,
MRD negativity and no previous BRAF i
113 age was P = .003; etap2 = 0.08, followed by
post hoc analyses of age subsamples.
114 Post hoc analyses of all treated attacks found a medium
115 Post hoc analyses of associations to psychosis symptoms
116 Post hoc analyses of baseline data were performed in two
117 Post hoc analyses of cardiac data from (1) studies in pa
118 Subsequent
post hoc analyses of clinical trial data alongside real-
119 Post hoc analyses of clinical trial data suggested that
120 including real-world effectiveness studies,
post hoc analyses of clinical trial data, and systematic
121 Post hoc analyses of clinical trials suggest pharmacolog
122 In all these cases, analyses and
post hoc analyses of data become relevant in informing p
123 Post hoc analyses of data from these large trials are co
124 Multiple observational studies and
post hoc analyses of datasets from randomized trials dem
125 Subsequent
post hoc analyses of dendritic parameters supported our
126 Current techniques are limited to
post hoc analyses of fixed tissues.
127 Post hoc analyses of flattened PED frequency at month 1,
128 In prespecified and
post hoc analyses of HF and related events, Cox proporti
129 Post hoc analyses of HYVET suggested that active hyperte
130 Post hoc analyses of large randomized clinical trials su
131 d survival in this subgroup was supported by
post hoc analyses of OS that categorized patients by the
132 al efficacy secondary end point analyses and
post hoc analyses of outcomes stratified by Trop-2 expre
133 Here, we report secondary and
post hoc analyses of participants' self-reported symptom
134 Post hoc analyses of patients with severe RAS (bilateral
135 , two randomised controlled trials, and four
post hoc analyses of randomised controlled trials).
136 trolled trials were analysed separately from
post hoc analyses of randomised controlled trials.
137 pective real-world studies and 13% to 35% in
post hoc analyses of randomized controlled studies of bi
138 ase (CYP7A1, rs3808607) genosets in previous
post hoc analyses of randomized controlled trials.
139 Multiple large observational studies and
post hoc analyses of randomized trials have established
140 Mendelian randomization studies and
post hoc analyses of randomized trials of LDL cholestero
141 mmentary we provide a critical assessment of
post hoc analyses of recent interventional and observati
142 Post hoc analyses of sample size indicated that a random
143 Post hoc analyses of selected genes showed that the gene
144 Recent
post hoc analyses of several clinical trials with P2Y12
145 earchers have until recently been limited to
post hoc analyses of significant gene lists.Method: We d
146 Post hoc analyses of sudden death, a secondary endpoint,
147 Post hoc analyses of the APOLLO-B trial (NCT03997383) ev
148 A mixed model repeated measures was used for
post hoc analyses of the area under the curve and peak C
149 Post hoc analyses of the ASCEND trial suggest that routi
150 th lower anemia risk, based on findings from
post hoc analyses of the CREDENCE and DAPA-CKD trials; h
151 In addition,
post hoc analyses of the datasets and challenge results
152 However, exploratory
post hoc analyses of the lobular BC (LBC) subgroup indic
153 Post hoc analyses of the PAC-Man Study data set revealed
154 Six
post hoc analyses of the previously published Hypertensi
155 Post hoc analyses of the structural tractography pattern
156 of CPAP on hard cardiovascular outcomes, but
post hoc analyses of these RCTs have demonstrated improv
157 Post hoc analyses of this interval utilizing five common
158 persons with CKD are frequently derived from
post hoc analyses of trials of broader populations.
159 Studies to date have been
post hoc analyses of trials, did not differentiate exace
160 udies of both prospective and retrospective (
post hoc) analyses of nutrition, genetic variants, and d
161 We conducted secondary
post-hoc analyses of a dataset consisting of volunteers
162 Post-hoc analyses of a variety of prospective trials hav
163 Post-hoc analyses of an open cohort from an observationa
164 Post-hoc analyses of clinical trials involving Ixekizuma
165 Epidemiological studies and
post-hoc analyses of clinical trials of corticosteroid t
166 Post-hoc analyses of ENCHANTED, an international, partia
167 We undertook
post-hoc analyses of mosquito catches made in The Gambia
168 In
post-hoc analyses of patients with nonalcoholic fatty li
169 evels of <4 or <6 million (M) IU/mL based on
post-hoc analyses of phase 3 trial data.
170 major cardiovascular events, consistent with
post-hoc analyses of previous fibrate trials.
171 Post-hoc analyses of screening data revealed excellent p
172 Post-hoc analyses of two clinical trials that characteri
173 Post hoc analyses on PTE's associations with cortical st
174 e depth, SNP identification methodology, and
post hoc analyses on SNP discovery rates.
175 Post hoc analyses on subnetworks did not reveal diagnosi
176 We performed
post hoc analyses on the utility of pretherapeutic and e
177 We performed
post-hoc analyses on the utility of pre-therapeutic and
178 Post hoc analyses per the 2014 Lugano classification, in
179 Design, Setting, and Participants:
Post hoc analyses performed from May 3, 2016, to June 21
180 In
post hoc analyses pooling phase 2 and 3 critical patient
181 utcomes, evaluations of participant subsets,
post hoc analyses,
problematic interpretations of the da
182 Post hoc analyses provided weak evidence of increased mo
183 The
post hoc analyses reported here sought to determine the
184 In
post hoc analyses restricted to patients enrolling under
185 A series of
post hoc analyses resulted in a significantly enriched p
186 In
post hoc analyses,
results were more consistent for thos
187 Post hoc analyses revealed a significant association of
188 Post hoc analyses revealed a significant difference betw
189 Post hoc analyses revealed low mental health symptoms at
190 Post hoc analyses revealed maximum efficacy at 2 weeks (
191 Post hoc analyses revealed reduced reflex facilitation i
192 Post hoc analyses revealed significant (interaction) eff
193 Post hoc analyses revealed significant activation decrea
194 Post hoc analyses revealed significant differences in th
195 Post hoc analyses revealed that antidepressants signific
196 The
post hoc analyses revealed that in the dorsal mid-insula
197 Post hoc analyses revealed that OB individuals exhibited
198 Post hoc analyses revealed that the number of criticisms
199 Post hoc analyses revealed that the odds of people with
200 Post hoc analyses revealed that the Parkinson disease gr
201 Post hoc analyses revealed that whereas healthy voluntee
202 Post-hoc analyses revealed a reduced annual relapse rate
203 p interactions were observed, and subsequent
post-hoc analyses revealed that female individuals with
204 Post-hoc analyses revealed that more posterior coil posi
205 ANOVA and
post-hoc analyses revealed that OBP had significantly lo
206 Post-hoc analyses revealed that participants in the 9 h
207 Although not predicted,
post-hoc analyses revealed that sleep cues strengthened
208 Post-hoc analyses revealed that the glutamine/glutamate
209 dition and competency of advisor and further
post-hoc analyses revealed that this effect was more pro
210 Post-hoc analyses revealed this effect to occur in corti
211 Conclusions and Relevance: Although
post hoc analyses should be viewed with caution given th
212 Post hoc analyses show that this relationship was relate
213 Post -hoc analyses showed that after a 12-week induction
214 Post hoc analyses showed a significant difference at wee
215 h the cortical distribution of D2 receptors,
post hoc analyses showed enhanced decoding of motor sign
216 Post hoc analyses showed no effect modification by sex o
217 Post hoc analyses showed that ADHD patients who received
218 Post hoc analyses showed that background bosentan use an
219 Post hoc analyses showed that during face (but not objec
220 Post hoc analyses showed that intensity of constant pain
221 Post hoc analyses showed that later age of depression on
222 Post hoc analyses showed that objective response rates a
223 Post hoc analyses showed that patients with AD who had a
224 Post hoc analyses showed that the changes were driven by
225 Post hoc analyses showed that the development of antisoc
226 Post hoc analyses showed that the overall median time to
227 Post hoc analyses showed that the relationship between I
228 Post hoc analyses showed that these associations were no
229 age and epilepsy [F(2,60) = 3.74, P = 0.03]:
post hoc analyses showed, for healthy children, activati
230 ased on group (F(3, 127) = 3.46, p = 0.019);
post-hoc analyses showed a positive association between
231 Post-hoc analyses showed LBP, sCD14, and LBP/sCD14 were
232 For both SNPs,
post-hoc analyses showed that in the group carrying the
233 In
post hoc analyses,
significant differences in favor of a
234 In
post hoc analyses,
steroid treatment had an impact on su
235 Post hoc analyses stratified patients with FND by mental
236 t failure with reduced ejection fraction and
post hoc analyses suggest favorable kidney effects.
237 RATIONALE:
Post hoc analyses suggest that blood eosinophils have po
238 d no effect following visual study, although
post hoc analyses suggest that participants who received
239 Post hoc analyses suggest that rates of death and bronch
240 d not meet its primary endpoint, exploratory
post hoc analyses suggest that selonsertib may slow diab
241 Post-hoc analyses suggest that ETC-1002 may have favorab
242 Although the VHS had no overall effect,
post-hoc analyses suggest VHS might be effective in redu
243 Exploratory
post hoc analyses suggested a trend toward better iDFS o
244 Post hoc analyses suggested effectiveness was more consi
245 Post hoc analyses suggested lower mean (SD) HDDs (eg, at
246 Post hoc analyses suggested that LNS benefited gross mot
247 Post hoc analyses suggested that patients not capable of
248 Post hoc analyses suggested that these differences were
249 Post hoc analyses suggested that this effect was specifi
250 Post hoc analyses suggested that treatment effects on br
251 Post hoc analyses suggested this difference was primaril
252 Post hoc analyses suggests that failure to reach the pri
253 Post hoc analyses supported longitudinal increases in AI
254 The VICTOR biobank was used in a series of
post hoc analyses that yielded unique and clinically val
255 In
post hoc analyses,
the 300-mg maintenance dose performed
256 In these
post hoc analyses,
the annual moderate and severe exacer
257 In planned
post hoc analyses,
the authors examined associations bet
258 In these
post hoc analyses,
the authors examined whether the prim
259 In
post hoc analyses,
the effect of treatment seemed to be
260 In
post hoc analyses,
the HTBC was compared with a historic
261 In
post hoc analyses,
the interaction between study arm and
262 In
post hoc analyses,
the proportions of abatacept-treated
263 In these
post-hoc analyses,
the beneficial effect of RNS60 on sur
264 In
post hoc analyses,
those with primary post-mortem diagno
265 We performed
post hoc analyses to determine whether high PRS for CAD
266 We performed
post hoc analyses to evaluate the effect of humanized mo
267 Exploratory
post hoc analyses using data from the Serine Protease In
268 In
post hoc analyses,
VM CPM and time spent in moderate/vig
269 vor of omapatrilat observed in secondary and
post hoc analyses warrant further study.
270 Using
post-hoc analyses we identified two groups of subjects w
271 In
post hoc analyses,
we aimed to identify associations bet
272 In
post hoc analyses,
we assessed changes in invasive coron
273 In
post hoc analyses,
we compared patients with or without
274 In
post hoc analyses,
we detected 98% of the attempts by th
275 Here, in
post-hoc analyses,
we report durable prolongation of ove
276 In
post hoc analyses,
weight loss of 5 kg or more within th
277 Post hoc analyses were additionally performed.
278 These
post hoc analyses were based on 566 women participating
279 Post hoc analyses were carried out to evaluate safety an
280 09 and was completed in August 2012, and the
post hoc analyses were conducted between October 2016 an
281 Post hoc analyses were conducted in participants with QI
282 an, 95% CIs) were performed for all attacks;
post hoc analyses were conducted in patients with at lea
283 r assess the impact of epoetin alfa on HRQL,
post hoc analyses were conducted in the same patient pop
284 Post hoc analyses were conducted investigating possible
285 Subsequent
post hoc analyses were conducted to address further cuto
286 Post hoc analyses were conducted to evaluate the effect
287 Post hoc analyses were conducted to evaluate the timecou
288 Post hoc analyses were conducted to examine health behav
289 Post hoc analyses were consistent with other studies tha
290 Post hoc analyses were performed after stratifying on a
291 Post hoc analyses were performed by menopausal status.
292 as used to evaluate overall differences, and
post hoc analyses were performed by using the Wilcoxon s
293 Results:
Post hoc analyses were performed for 660 participants (m
294 Post hoc analyses were performed to assess differences b
295 Post hoc analyses were performed to explore the possible
296 Post hoc analyses were performed to identify any subgrou
297 Post hoc analyses were performed to test additional clar
298 The
post-hoc analyses were of cardiovascular death and hospi
299 ANOVA followed by Newman-Keuls
post-hoc analyses were used to test for differences betw
300 s well as primary and secondary outcomes and
post hoc analyses,
were summarized.